Ms. Judith Louise Streamer, RNFA Clinical Nurse Specialist - Perioperative Medicare: Not Enrolled in Medicare Practice Location: 315 S Dos Caminos Ave, Ventura, CA 93003 Phone: 805-642-0917 |
Anne Marie Tumbarello, APRN, BC Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 300 Hillmont Ave, Ventura, CA 93003 Phone: 805-652-6152 |
Linda Jean Hitt, Clinical Nurse Specialist - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 888 S Hill Rd, Ventura, CA 93003 Phone: 805-477-6464 Fax: 805-477-6498 |
News Archive
More than one-third of adults ages 65 and older fall each year in the U.S., and, according to the Centers for Disease Control, 40 percent of all seniors admitted to the hospital are there due to injuries from falls. However, a new study has found that falls are not just a problem for older adults. Researchers have found that people in their 20s and 30s have significant issues affecting their balance, indicating an increased risk for falling.
Many people turn to artificial or so-called natural sweeteners to cut calories and lose weight. A new study led by Dr. Raylene Reimer, PhD, published in the high-impact journal Gut discovered that the consumption of low-calorie sweeteners while pregnant increased body fat in their offspring and disrupted their gut microbiota - the trillions of bacteria and other microorganisms that inhabit the intestinal tract and affect our health and risk of numerous diseases.
A type of brain cell that was long overlooked by researchers embodies one of very few ways in which the human brain differs fundamentally from that of a mouse or rat, according to researchers who published their findings as the cover story in the March 11 issue of the Journal of Neuroscience.
LTS LOHMANN Therapie-Systeme AG, the leading developer and manufacturer of transdermal, topical and oral systems with facilities in Andernach, Germany and West Caldwell, New Jersey, celebrates its 25th anniversary.
Arena Pharmaceuticals, Inc. announced today that, following the completion of a Phase 1 clinical trial program for APD597 (JNJ-38431055) under its collaboration with Arena, Ortho-McNeil-Janssen Pharmaceuticals, Inc., has decided not to advance APD597 and has notified Arena that it is terminating the collaboration, effective December 28, 2010.
› Verified 2 days ago